Thermogenesis Holdings Inc 's ability to collect accounts receivable sequentially worsen to 10.57, indicating more challenging environment then in the fourth quarter 2023, but still, it is a far cry from any concerns. Thermogenesis Holdings Inc 's Accounts Receivable average collection period in the Mar 31 2024 quarter, has increased to 35 days, from 31 days, in the Dec 31 2023 quarter.

If we take a look into Healthcare sector 205 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2024 from 1120 to 1736.

What is Receivable Turnover Ratio?
What is Thermogenesis Holdings Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

THMO Receivables Turnover Ratio	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter
Y / Y Receivable Change	20.31 %	-49.12 %	-82.1 %	-66.48 %	-56.09 %
Y / Y Revenue Change	-14.39 %	30.61 %	-34.04 %	-51.5 %	-3.42 %
Receivable Turnover Ratio (TTM)	10.57	11.73	8.19	6.25	5.79
THMO's Total Ranking	# 1736	# 1120	# 2140	# 1457	# 1657
Accounts Receivable average collection period days	35	31	45	58	63
Seq. Receivable Change	21.07 %	157.88 %	-52.45 %	-18.95 %	-48.79 %
Seq. Revenue Change	-37 %	150.54 %	-5.04 %	-42.88 %	-3.89 %

Receivable Turnover Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 7
Healthcare Sector	# 206
Overall Market	# 1736

Receivable Turnover Ratio Statistics
High	Average	Low
1	0.47	0.24
(Dec 31 2013)		(Jun 30 2016)

THMO Company Profile • Back to THMO Efficiency Comparisons • Compare THMO Receivables Turnover Ratio to its Competitors

Financial Statements
Thermogenesis Holdings Inc 's Accounts Receivable	$ 1 Millions	Visit THMO's Balance sheet
Thermogenesis Holdings Inc 's Sales TTM	$ 9 Millions	Visit THMO's Income Statement
Sources of THMO's Revenues		Visit THMO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
THMO's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
THMO's Growth Rates	THMO's Roa	THMO's Inventory Turnover Ratio	THMO's Dividend Comparisons
THMO's Profitability Ratios	THMO's Roi	THMO's Asset Turnover Ratio	THMO's Dividend Growth
THMO's Valuation Ratios	THMO's Roe	THMO's Financial Strength Ratios	THMO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2024	Receivable at quarter ending Mar 31 2024
Ginkgo Bioworks Holdings Inc	19.85	$ 208.697 Millions	$ 10.516 Millions
Zivo Bioscience Inc	19.47	$ 0.063 Millions	$ 0.003 Millions
Innovage Holding Corp	19.44	$ 741.328 Millions	$ 38.140 Millions
Lineage Cell Therapeutics Inc	18.86	$ 8.003 Millions	$ 0.424 Millions
Scorpius Holdings inc	18.69	$ 9.743 Millions	$ 0.521 Millions
Sab Biotherapeutics Inc	18.68	$ 2.602 Millions	$ 0.139 Millions
Kiniksa Pharmaceuticals International Plc	18.58	$ 301.772 Millions	$ 16.238 Millions
Hookipa Pharma inc	18.38	$ 53.552 Millions	$ 2.913 Millions
Editas Medicine Inc	18.34	$ 69.407 Millions	$ 3.785 Millions
Iovance Biotherapeutics inc	18.22	$ 1.904 Millions	$ 0.105 Millions
Greenbrook Tms Inc	17.56	$ 102.934 Millions	$ 5.863 Millions
Jrsis Health Care Corp	17.28	$ 3.962 Millions	$ 0.229 Millions
Neuraxis Inc	17.26	$ 2.302 Millions	$ 0.133 Millions
Talkspace Inc	17.10	$ 160.775 Millions	$ 9.400 Millions
Pulmatrix Inc	16.95	$ 11.684 Millions	$ 0.689 Millions
Amneal Pharmaceuticals Inc	16.18	$ 2,495.439 Millions	$ 154.251 Millions
Wave Life Sciences Ltd	16.08	$ 112.914 Millions	$ 7.022 Millions
Milestone Scientific Inc	16.04	$ 9.444 Millions	$ 0.589 Millions
Qhslab Inc	15.95	$ 1.545 Millions	$ 0.097 Millions
Recursion Pharmaceuticals Inc	15.53	$ 46.235 Millions	$ 2.977 Millions
Marizyme Inc	15.52	$ 0.550 Millions	$ 0.035 Millions
Fortress Biotech Inc	15.24	$ 85.114 Millions	$ 5.583 Millions
Nexalin Technology Inc	15.19	$ 0.159 Millions	$ 0.010 Millions
China Health Industries Holdings Inc	14.34	$ 0.061 Millions	$ 0.004 Millions
Icu Medical Inc	14.31	$ 2,256.721 Millions	$ 157.694 Millions
Ensysce Biosciences Inc	14.23	$ 2.101 Millions	$ 0.148 Millions
Chemed Corporation	14.18	$ 2,293.493 Millions	$ 161.797 Millions
Precipio inc	13.83	$ 15.812 Millions	$ 1.144 Millions
Innovative Eyewear Inc	13.76	$ 1.391 Millions	$ 0.101 Millions
Rosecliff Acquisition Corp I	13.76	$ 19.304 Millions	$ 1.403 Millions

Date modified: 2026-09-08T15:11:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.